Тактика мукоактивной терапии в педиатрической практике

Мизерницкий Юрий Леонидович, И М Мельникова, Б Ц Батожаргалова et al. · Pacific Medical Journal · 2011

The authors provide detailed analysis of the present-day data about the mucoactive therapy methods. The multi-focus clinical examinations allowed finding out that the lysine salt of carbocisteine is highly efficient to be prescribed as mucoactive drug to children suffering from acute respiratory infections of lower respiratory ways and those with exacerbated chronic bronchopulmonary diseases, including bronchial asthma. The authors consider tobacco smoking to be a negative factor in treating children suffering from this pathology, including the active one known to be associated with the hyperproduction of sputum, against the background of expectorant therapy and low recovery reserves of the local immunity. The mucoactive therapy should be chosen based upon a number of individual features of a patient, its age, peculiarities of the tussive syndrome, knowledge of pharmacological properties of a drug, and negative factors that appear to affect the efficiency of therapy.

Cited by 0 works.

Authors